FIRSTT study: randomized controlled trial of uterine artery embolization vs focused ultrasound surgery

[1]  A. Weaver,et al.  Cardiovascular and metabolic morbidity after hysterectomy with ovarian conservation: a cohort study , 2017, Menopause.

[2]  Michael J. Miller,et al.  Periprocedural outcomes comparing fibroid embolization and focused ultrasound: a randomized controlled trial and comprehensive cohort analysis , 2017, American journal of obstetrics and gynecology.

[3]  Michael J. Miller,et al.  Fibroid interventions: reducing symptoms today and tomorrow: extending generalizability by using a comprehensive cohort design with a randomized controlled trial. , 2016, American journal of obstetrics and gynecology.

[4]  E. Vittinghoff,et al.  PROMISe trial: a pilot, randomized, placebo-controlled trial of magnetic resonance guided focused ultrasound for uterine fibroids. , 2016, Fertility and sterility.

[5]  J. Reekers,et al.  Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 10-year outcomes from the randomized EMMY trial. , 2007, American journal of obstetrics and gynecology.

[6]  R. Stahl,et al.  MRI predictors of clinical success in MR-guided focused ultrasound (MRgFUS) treatments of uterine fibroids: results from a single centre , 2015, European Radiology.

[7]  B. Hamm,et al.  Outcome of uterine artery embolization versus MR-guided high-intensity focused ultrasound treatment for uterine fibroids: long-term results. , 2013, European journal of radiology.

[8]  M. Reiser,et al.  Magnetic Resonance Imaging–Guided Focused Ultrasound Treatment of Symptomatic Uterine Fibroids: Impact of Technology Advancement on Ablation Volumes in 115 Patients , 2013, Investigative radiology.

[9]  L. Cohen,et al.  Racial differences in fibroid prevalence and ultrasound findings in asymptomatic young women (18-30 years old): a pilot study. , 2013, Fertility and sterility.

[10]  R. Robles,et al.  Laparoscopic radiofrequency volumetric thermal ablation of uterine myomas with 12 months of follow‐up , 2013, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[11]  K. Coyne,et al.  Further validation of the uterine fibroid symptom and quality-of-life questionnaire. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[12]  A. Weaver,et al.  Comparing focused ultrasound and uterine artery embolization for uterine fibroids-rationale and design of the Fibroid Interventions: reducing symptoms today and tomorrow (FIRSTT) trial. , 2011, Fertility and sterility.

[13]  M. Lumsden,et al.  Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5‐year results , 2011, BJOG : an international journal of obstetrics and gynaecology.

[14]  Kimberly K Amrami,et al.  Magnetic resonance-guided focused ultrasound of uterine leiomyomas: review of a 12-month outcome of 130 clinical patients. , 2011, Journal of vascular and interventional radiology : JVIR.

[15]  J. Reekers,et al.  Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5-year outcome from the randomized EMMY trial. , 2010, American journal of obstetrics and gynecology.

[16]  C. Tempany,et al.  Magnetic resonance‐guided focused ultrasound (MRgFUS) compared with abdominal hysterectomy for treatment of uterine leiomyomas , 2009, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[17]  J. de Vries,et al.  Sexual functioning and psychological well-being after uterine artery embolization in women with symptomatic uterine fibroids. , 2009, Fertility and sterility.

[18]  D. Baird,et al.  Prevalence of Uterine Leiomyomas in the First Trimester of Pregnancy: An Ultrasound-Screening Study , 2009, Obstetrics and gynecology.

[19]  E. Peterson,et al.  Uterine Artery Embolization for Treatment of Leiomyomata: Long-Term Outcomes From the FIBROID Registry , 2008, Obstetrics and gynecology.

[20]  J. Reekers,et al.  Sexuality and Body Image After Uterine Artery Embolization and Hysterectomy in the Treatment of Uterine Fibroids: A Randomized Comparison , 2007, CardioVascular and Interventional Radiology.

[21]  C. Tempany,et al.  Sustained Relief of Leiomyoma Symptoms by Using Focused Ultrasound Surgery , 2007, Obstetrics and gynecology.

[22]  K. Lohr,et al.  Management of uterine fibroids: an update of the evidence. , 2007, Evidence report/technology assessment.

[23]  L. Murray,et al.  Uterine-artery embolization versus surgery for symptomatic uterine fibroids. , 2007, The New England journal of medicine.

[24]  S. Datta,et al.  Health care resource use for uterine fibroid tumors in the United States. , 2006, American journal of obstetrics and gynecology.

[25]  M. Farrell,et al.  Annual Costs Associated With Diagnosis of Uterine Leiomyomata , 2006, Obstetrics and gynecology.

[26]  Elizabeth A Stewart,et al.  Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids. , 2006, Fertility and sterility.

[27]  K. Coyne,et al.  The UFS‐QOL, a New Disease‐Specific Symptom and Health‐Related Quality of Life Questionnaire for Leiomyomata , 2002, Obstetrics and gynecology.

[28]  Candace S. Brown,et al.  The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. , 2000, Journal of sex & marital therapy.

[29]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .